Age-related macular degeneration (AMD) Market is expected to showcase exceptional Growth by 2032 – Estimates DelveInsight | Key Companies- Roche, Opthea Limited, Apellis Pharma, IVERIC Bio, Novartis, & Others
Age-related macular degeneration (AMD) is a neurodegenerative disease of the aging retina, in which patients experience severe vision loss. AMD is one of the most prevalent ocular conditions in developed countries with more than 10 million US adults affected by AMD. Based on severity of the disease, It is of three stages: Early, Intermediate and Late-stage; Late stage AMD is of two types: Dry AMD and Neovascular AMD (nAMD).
AMD’s progression leads to loss of central vision, leaving
many patients unable to read, write, or recognize both color and detail, thus
compromising the quality of life. Although AMD’s exact functional pathogenesis
is not fully understood, there have been recent improvements in genetic
technologies leading to the identification of various polymorphisms that have
shown to harbor unique associations with AMD. This has led to identification of
many new targets for controlling disease progression.
Click here to Request
for Age Related Macular Degeneration Market Sample Page: https://www.delveinsight.com/report-store/age-related-macular-degeneration-market
DelveInsight's "Age
Related Macular Degeneration Market Insights, Epidemiology, and Market
Forecast-2032" report delivers an in-depth understanding of the
Age Related Macular Degeneration, historical and forecasted epidemiology as
well as the Age Related Macular Degeneration market trends in the United
States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Age-related
macular degeneration (AMD) Market Report
·
According to Ayoub et al., Age-related macular degeneration
(AMD) is the leading cause of blindness and visual disability in patients aged over
60 years in Europe and North America. It is the third leading cause of
blindness, behind cataract and glaucoma, causing 8.7% of all legal blindness
across the world.
·
Globally, around 20 million people are living with
nAMD – the leading cause of cause of vision loss in people over the age of 60.
·
According to Braclay et al. (2021), based on types
of AMD, dry AMD accounts for nearly 85-90% of the cases and Neovascular AMD (nAMD)
accounts for only 10% of the cases, but nAMD is responsible for nearly 90% of
the severe, central visual acuity loss associated with AMD.
·
According to Schwatz et al. (2021), dry AMD prevalence
was reported as 0.44% globally, with similar or slightly higher values reported
for wet AMD. Dry AMD prevalence varied across ethnic groups (1.11% European,
0.21% Asian, 0.16% Hispanic, and 0.14% African).
·
According to DelveInsight’s analysis, AMD is more
prominent in females in comparison to males.
·
Among the age-specific cases of AMD, 61-70 years
of age represents the biggest category, followed by 51-60 years of age.
·
The prevalence of AMD is poised to increase due
to the increase in geriatric population in all 7MM.
Click here to Request
for Age Related Macular Degeneration Market Sample Page: https://www.delveinsight.com/report-store/age-related-macular-degeneration-market
Scope of the Age-related
macular degeneration (AMD) Market Report
- The
report covers the descriptive overview of Age Related Macular
Degeneration, explaining its causes, signs and symptoms, pathophysiology,
diagnosis and currently available therapies
- Comprehensive
insight has been provided into the Age Related Macular Degeneration
epidemiology and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Age Related Macular Degeneration is provided, along with the assessment of
new therapies, which will have an impact on the current treatment
landscape
- A
detailed review of the Age Related Macular Degeneration market; historical
and forecasted is included in the report, covering drug outreach in the
7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Age Related Macular
Degeneration market.
Click here to Request
for Age Related Macular Degeneration Market Sample Page: https://www.delveinsight.com/report-store/age-related-macular-degeneration-market
Age-related macular
degeneration (AMD) Companies are:
·
Roche
·
Opthea Limited
·
Apellis Pharma
·
IVERIC Bio
·
Novartis
·
Regeneron Pharmaceuticals
·
And Others
To get detailed
insights into Age-related macular degeneration Pipeline therapies and companies
working in the domain, Click here: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-market
Age-related macular
degeneration (AMD) Pipeline Drugs and Therapies:
·
Faricimab
·
OPT-302
·
APL-2
·
Beovu
·
Lucentis
·
Eylea
·
And Others
To get competitive
insights into Age-related macular degeneration Pipeline, Click here: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-market
Table of Content
1. Key Insights
2. Executive Summary
3. Age-related macular degeneration Competitive Intelligence
Analysis
4. Age-related macular degeneration Market Overview at a
Glance
5. Age-related macular degeneration Disease Background and
Overview
6. Age-related macular degeneration Patient Journey
7. Age-related macular degeneration Epidemiology and Patient
Population
8. Age-related macular degeneration Treatment Algorithm,
Current Treatment, and Medical Practices
9. Age-related macular degeneration Unmet Needs
10. Key Endpoints of Age-related macular degeneration
Treatment
11. Age-related macular degeneration Marketed Products
12. Age-related macular degeneration Emerging Therapies
13. Age-related macular degeneration Seven Major Market
Analysis
14. Attribute Analysis
15. Age-related macular degeneration Market Outlook (7 major
markets)
16. Age-related macular degeneration Access and
Reimbursement Overview
17. KOL Views on the Age-related macular degeneration
Market.
18. Age-related macular degeneration Market Drivers
19. Age-related macular degeneration Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research Firm focused exclusively on life sciences. It supports pharma
companies by providing end-to-end comprehensive solutions to improve their
performance.
·
Central Retinal Vein Occlusion Market
·
Microsatellite Stable Colorectal
Cancer Market
·
Progressive Multifocal
Leukoencephalopathy Market
·
Prosthetic Joint Infection Market
·
Higher-Risk Chronic Myelomonocytic Leukemia
Market
·
Upper Limb Hypertonia Market
·
X-linked Retinitis Pigmentosa Market
·
Metachromatic Leukodystrophy Market
·
Idiopathic Membranous Nephropathy Market
·
Nevoid Basal Cell Carcinoma Syndrome Market
·
Chronic Refractory Cough Market
·
Cardiopulmonary Bypass Equipment Market
·
Cardiac Biomarkers Testing Devices Market
·
Epithelial Ovarian Cancer Market
·
Surgical Site Infection Ssi Market
·
Synchronous Endometrial And Ovarian Carcinoma
Market
·
Autosomal Recessive Congenital Ichthyosis
Market
·
Rituximab Biosimilars Insight
·
Pain Management Devices Market
·
Continuous Renal Replacement Therapy Machines
Market
·
Parkinsons Disease Related Dementia Market
·
22q11.2 Deletion Syndrome Market
·
Pediatric Growth Hormone Deficiency Pghd
Market
·
Brain Aneurysm Stents Market
·
Pelvic Inflammatory Disease Market
·
Polypoidal Choroidal Vasculopathy Market
Comments
Post a Comment